Eagle Global Advisors’s St Jude Medical STJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-6,905
Closed -$554K 420
2016
Q4
$554K Sell
6,905
-1,100
-14% -$87.3K 0.02% 197
2016
Q3
$638K Sell
8,005
-1,758
-18% -$142K 0.02% 176
2016
Q2
$762K Sell
9,763
-1,855
-16% -$132K 0.02% 160
2016
Q1
$639K Sell
11,618
-123,310
-91% -$6.72M 0.02% 172
2015
Q4
$8.34M Sell
134,928
-5,034
-4% -$317K 0.29% 77
2015
Q3
$8.83M Buy
139,962
+64,056
+84% +$4.57M 0.29% 72
2015
Q2
$5.55M Buy
75,906
+2,776
+4% +$201K 0.14% 111
2015
Q1
$4.78M Sell
73,130
-1,140
-2% -$75.8K 0.13% 117
2014
Q4
$4.83M Sell
74,270
-999
-1% -$64.3K 0.12% 121
2014
Q3
$4.53M Sell
75,269
-172
-0.2% -$11.2K 0.11% 119
2014
Q2
$5.22M Sell
75,441
-375
-0.5% -$24.3K 0.13% 108
2014
Q1
$4.96M Sell
75,816
-1,360
-2% -$88.5K 0.15% 106
2013
Q4
$4.78M Sell
77,176
-2,734
-3% -$158K 0.15% 112
2013
Q3
$4.29M Sell
79,910
-898
-1% -$46.2K 0.15% 111
2013
Q2
$3.69M Buy
+80,808
New +$3.5M 0.14% 118

Other funds holding STJ

Eagle Global Advisors's STJ Position: Q1 2017 in Review

Eagle Global Advisors sold out of St Jude Medical (STJ) in Q1 2017, closing a stake of 6,905 shares — an estimated $554K sold.

Eagle Global Advisors first reported a position in STJ in Q2 2013 and held it in 15 quarters. The position peaked at $8.83M in Q3 2015. 4 funds tracked by Wall St. Rank hold STJ as of Q1 2017.

  • Eagle Global Advisors reported no remaining St Jude Medical position as of Q1 2017 after selling out during the quarter.
  • Eagle Global Advisors sold 6,905 St Jude Medical shares in Q1 2017, an estimated $554K.
  • Eagle Global Advisors first reported a position in St Jude Medical in Q2 2013 and held it in 15 quarters.
  • Eagle Global Advisors's St Jude Medical position peaked at $8.83M in Q3 2015.
  • 4 funds tracked by Wall St. Rank held St Jude Medical as of Q1 2017.

Based on Eagle Global Advisors's 13F filing for Q1 2017, filed 9 May 2017.